193 related articles for article (PubMed ID: 25520448)
1. Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.
Levesque E; El Anbassi S; Sitterle E; Foulet F; Merle JC; Botterel F
J Clin Microbiol; 2015 Mar; 53(3):771-6. PubMed ID: 25520448
[TBL] [Abstract][Full Text] [Related]
2. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
[TBL] [Abstract][Full Text] [Related]
3. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
[TBL] [Abstract][Full Text] [Related]
4. Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.
Mohr JF; Sims C; Paetznick V; Rodriguez J; Finkelman MA; Rex JH; Ostrosky-Zeichner L
J Clin Microbiol; 2011 Jan; 49(1):58-61. PubMed ID: 21048005
[TBL] [Abstract][Full Text] [Related]
5. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
[TBL] [Abstract][Full Text] [Related]
6. [The 1,3-β-d-glucan in critical adult patients as diagnostic tool for invasive Candida spp. infection, performance evaluation].
Donato L; González T; Canales M; Legarraga P; García P; Rabagliati R
Rev Chilena Infectol; 2017 Aug; 34(4):340-346. PubMed ID: 29165510
[TBL] [Abstract][Full Text] [Related]
7. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
[TBL] [Abstract][Full Text] [Related]
8. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
[TBL] [Abstract][Full Text] [Related]
9. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
Koo S; Baden LR; Marty FM
Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
[TBL] [Abstract][Full Text] [Related]
10. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.
Posteraro B; De Pascale G; Tumbarello M; Torelli R; Pennisi MA; Bello G; Maviglia R; Fadda G; Sanguinetti M; Antonelli M
Crit Care; 2011; 15(5):R249. PubMed ID: 22018278
[TBL] [Abstract][Full Text] [Related]
11. Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.
Lo Cascio G; Koncan R; Stringari G; Russo A; Azzini A; Ugolini A; Ligozzi M; Polati E; Cornaglia G; Concia E; Schweiger V
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):357-65. PubMed ID: 25217227
[TBL] [Abstract][Full Text] [Related]
12. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
Jaijakul S; Vazquez JA; Swanson RN; Ostrosky-Zeichner L
Clin Infect Dis; 2012 Aug; 55(4):521-6. PubMed ID: 22573851
[TBL] [Abstract][Full Text] [Related]
13. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
15. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
Pini P; Colombari B; Marchi E; Castagnoli A; Venturelli C; Sarti M; Blasi E
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):39-43. PubMed ID: 30098849
[No Abstract] [Full Text] [Related]
16. β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.
Tissot F; Lamoth F; Hauser PM; Orasch C; Flückiger U; Siegemund M; Zimmerli S; Calandra T; Bille J; Eggimann P; Marchetti O;
Am J Respir Crit Care Med; 2013 Nov; 188(9):1100-9. PubMed ID: 23782027
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
18. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
19. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
20. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
